References
- Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. doi:https://doi.org/10.1191/1478088706qp063oa
- Braun, V., & Clarke, V. (2019). Reflecting on reflexive thematic analysis. Qualitative Research in Sport, Exercise and Health, 11(4), 589–597. doi:https://doi.org/10.1080/2159676X.2019.1628806
- Cope, N. (2003). ‘It’s No Time or High Time’: Young Offenders’ Experiences of Time and Drug Use in Prison. The Howard Journal of Criminal Justice, 42(2), 158–175. doi:https://doi.org/10.1111/1468-2311.t01-1-00273
- Corazza, O., Coloccini, S., Marrinan, S., Vigar, M., Watkins, C., Zene, C., Negri, A., Aresti, A., Darke, S., Rinaldi, R., Metastasio, A., & Bersani, G. (2020). Novel Psychoactive Substances in Custodial Settings: A Mixed Method Investigation on the Experiences of People in Prison and Professionals Working With Them. Frontiers in Psychiatry, 11, 1. doi:https://doi.org/10.3389/fpsyt.2020.00460
- Corazza, O., & Roman-Urrestarazu, A. (2018). Handbook of Novel Psychoactive Substances What Clinicians Should Know about NPS (1stEdition ed.). Routledge.
- Department of Health (2015) NHS reference costs 2013-2014, available at: https://www.pssru.ac.uk/wp-content/uploads/2017/10/2.1-NHS-reference-costs-for-mental-health-services.pdf (accessed November 2020)
- Duke, K. (2019). Producing the ‘problem’ of new psychoactive substances (NPS)in English prisons. International Journal of Drug Policy, 80, 102479. doi:https://doi.org/10.1016/j.drugpo.2019.05.022
- EMCDDA (2018). European drug report 2018: Trends and developments Publications Office of the European Union.
- Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug and Alcohol Dependence, 117(2–3), 152–157. doi:https://doi.org/10.1016/j.drugalcdep.2011.01.012
- Goffman, E. (1974). Stigma; Notes on the management of spoiled identity. JASON ARONSON, NEW YORK, N.Y. https://doi.org/10.2307/2575995
- Gray, R., Bressington, D., Hughes, E., & Ivanecka, A. (2016). A systematic review of the effects of novel psychoactive substances “legal highs” on people with severe mental illness. Journal of Psychiatric and Mental Health Nursing, 23(5), 267–281. doi:https://doi.org/10.1111/jpm.12297
- Hagan, A. O. (2017). Behind Bars: The Truth about Drugs in Prisons. Forensic Research & Criminology International Journal, 5(3). doi:https://doi.org/10.15406/frcij.2017.05.00158
- Home Office. (2019). Drug misuse: findings from the 2018 to 2019 Crime Survey for England and Wales. Home Office Statistical Bulletin 21/19. London. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/832533/drug-misuse-2019-hosb2119.pdfAccessedon28thNovember2020
- Howard League for Penal Reform (2018). Latest prison population figures. http://www.howardleague.org
- Hughes, E., Bressington, D., Sharratt, K., & Gray, R. (2018). Novel psychoactive substance use by mental health service consumers: an online survey of inpatient health professionals’ views and experiences. Advances in Dual Diagnosis, 11(1), 30–39. doi:https://doi.org/10.1108/ADD-07-2017-0008
- Kalk, N. J., Boyd, A., Strang, J., & Finch, E. (2016). Spice and all things nasty: The challenge of synthetic cannabinoids. BMJ, i5639. https://doi.org/10.1136/bmj.i5639
- Lloyd, C., Page, G., McKeganey, N., & Russell, C. (2019). Capital depreciation: The lack of recovery capital and post-release support for prisoners leaving the Drug Recovery Wings in England and Wales. International Journal of Drug Policy, 70, 107–116. doi:https://doi.org/10.1016/j.drugpo.2019.06.012
- Lloyd, C., Perry, A., & Grace, S. (2018). “Spice” use among offenders supervised in approved premises and community rehabilitation companies: a preliminary qualitative study. https://www.york.ac.uk/media/healthsciences/images/research/prepare/SpiceUseAmongOffendersSupervisedInAPsandCRCs.pdf
- McFadden, D., Prior, K., & Barrett, E. L. (2020). A Substance Use Treatment Programme for Mentally Ill Forensic Patients in an Australian Setting: A Pilot Study of Feasibility, Acceptability and Preliminary Efficacy. International Journal of Mental Health and Addiction. doi:https://doi.org/10.1007/s11469-020-00348-3
- Mckenzie, E., & Harvey, J. (2019). The perceived challenges of working with patients who use new psychoactive substances: a qualitative study in a medium secure unit. Journal of Forensic Practice, 22(1), 12–22. doi:https://doi.org/10.1108/JFP-09-2019-0036
- Miles, H. (2015). “A new horizon?”: evaluation of an integrated substance use treatment programme (SUTP) for mentally disordered offenders. Advances in Dual Diagnosis, 8(2), 90–101. doi:https://doi.org/10.1108/ADD-03-2015-0002
- Miles, H., Dutheil, L., Welsby, I., & Haider, D. (2007). ‘Just say no’: a preliminary evaluation of a three-stage model of integrated treatment for substance use problems in conditions of medium security. Journal of Forensic Psychiatry & Psychology, 18(2), 141–159. doi:https://doi.org/10.1080/14789940601101897
- Ministry of Justice (2021). Restricted patients 2020 England and Wales. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/981888/Restricted_Patients_Statistical_Bulletin_2020.pdf
- Ministry of Justice and Safety in Custody Statistics, England and Wales. (2019). Deaths in Prison Custody to September 2019 Assaults and Self-harm to June 2019. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/843117/safety-in-custody-q2-2019.pdf
- Murray, R. M., Morrison, P. D., Henquet, C., & Forti, M. D. (2007). Cannabis, the mind and society: The hash realities. Nature Reviews Neuroscience, 8(11), 885–895. doi:https://doi.org/10.1038/nrn2253
- Norman, C., Halter, S., Haschimi, B., Acreman, D., Smith, J., Krotulski, A. J., Mohr, A. L. A., Logan, B. K., NicDaéid, N., Auwärter, V., & McKenzie, C. (2021). A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations. Drug Testing and Analysis, 13(4), 841–852. doi:https://doi.org/10.1002/dta.3002
- Pickard, H., & Fazel, S. (2013). Substance abuse as a risk factor for violence in mental illness: Some implications for forensic psychiatric practice and clinical ethics. Current Opinion in Psychiatry, 26(4), 349–354. doi:https://doi.org/10.1097/YCO.0b013e328361e798
- Public Health England (2015). New Psychoactive Substances (NPS) in prisons: a toolkit for prison staff. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/669541/9011-phe-nps-toolkit-update-final.pdf
- Public Health England (2017). A review of new psychoactive substances in secure mental health settings. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/777629/Review_of_new_sychoactive_substances_in_secure_mental_health_settings.pdf
- QSR International Pty Ltd. 2018. NVivo Qualitative Data Analysis Software. Version, 12. Available from https://qsrinternational.com/nvivo/nvivo-products/
- Ralphs, R., Williams, L., Askew, R., & Norton, A. (2017). Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison. International Journal of Drug Policy, 40, 57–69. doi:https://doi.org/10.1016/j.drugpo.2016.10.003
- Royal College of Psychiatrists. (2020). Quality Network for Forensic Mental Health Service Membership. https://www.rcpsych.ac.uk/docs/default-source/improving-care/ccqi/quality-networks/secure-forensic/forensic-newsletters-qnfmhs/membership-list-2020-21.pdf?sfvrsn=a5200a6e_2
- Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020). New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology, 10, 204512532096719. doi:https://doi.org/10.1177/2045125320967197
- Soyka, M. (2000). Substance misuse, psychiatric disorder and violent and disturbed behaviour. British Journal of Psychiatry, 176(4), 345–350. doi:https://doi.org/10.1192/bjp.176.4.345
- Stevenson, R., & Tuddenham, L. (2014). Novel psychoactive substance intoxication resulting in attempted murder. Journal of Forensic and Legal Medicine, 25, 60–61. doi:https://doi.org/10.1016/j.jflm.2014.04.007
- Toftdahl, N. G., Nordentoft, M., & Hjorthøj, C. (2016). Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Social Psychiatry and Psychiatric Epidemiology, 51(1), 129–140. doi:https://doi.org/10.1007/s00127-015-1104-4
- Tompkins, C. N. E. (2016). “There’s that many people selling it”: Exploring the nature, organisation and maintenance of prison drug markets in England. Drugs: Education, Prevention and Policy. doi:https://doi.org/10.3109/09687637.2015.1085490
- Tracy, D. K., Wood, D. M., & Baumeister, D. (2017). Novel psychoactive substances: Types, mechanisms of action, and effects. BMJ, i6848. https://doi.org/10.1136/bmj.i6848
- Tyler, N., Miles, H. L., Karadag, B., & Rogers, G. (2019). An updated picture of the mental health needs of male and female prisoners in the UK: prevalence, comorbidity, and gender differences. Social Psychiatry and Psychiatric Epidemiology, 54(9), 1143–1152. doi:https://doi.org/10.1007/s00127-019-01690-1
- United Nations on Drug and Crime World Drug Report 2021: pandemic effects ramp up drug risks, as youth underestimate cannabis dangers. https://www.york.ac.uk/media/healthsciences/images/research/prepare/SpiceUseAmongOffendersSupervisedInAPsandCRCs.pdf
- User Voice (2016). Spice: The bird killer—what prisoners think about the use of spice and other legal highs in prison. http://www.uservoice.org/wp-content/uploads/2016/05/U